Reintroduction of Oxaliplatin: A Viable Approach to the Long-Term Management of Metastatic Colorectal CancerGROTHEY, Axel.Oncology. 2010, Vol 79, Num 5-6, pp 389-399, issn 0030-2414, 11 p.Article

Biomarkers of Resistance to Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients with Metastatic Colorectal CancerBANCK, Michaela S; GROTHEY, Axel.Clinical cancer research (Print). 2009, Vol 15, Num 24, pp 7492-7501, issn 1078-0432, 10 p.Article

Future directions in vascular endothelial growth factor-targeted therapy for metastatic colorectal cancerGROTHEY, Axel.Seminars in oncology. 2006, Vol 33, Num 5, issn 0093-7754, S41-S49, SUP10Article

Oxaliplatin-safety profile: NeurotoxicityGROTHEY, Axel.Seminars in oncology. 2003, Vol 30, Num 4, pp 5-13, issn 0093-7754, 9 p., SUP15Article

First- and second-line therapy of metastatic colorectal cancerTERSTRIEP, Shelby; GROTHEY, Axel.Expert review of anticancer therapy. 2006, Vol 6, Num 6, pp 921-930, issn 1473-7140, 10 p.Article

Biological Therapy and Other Novel Therapies in Early-Stage Disease : Are They Appropriate?GROTHEY, Axel.Clinical cancer research. 2007, Vol 13, Num 22, issn 1078-0432, 6909s-6912sConference Paper

Is there a third-line therapy for metastatic colorectal cancer?GROTHEY, Axel.Seminars in oncology. 2006, Vol 33, Num 6, issn 0093-7754, S36-S38, SUP11Conference Paper

Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatmentGROTHEY, Axel; SARGENT, Daniel; GOLDBERG, Richard M et al.Journal of clinical oncology. 2004, Vol 22, Num 7, pp 1209-1214, issn 0732-183X, 6 p.Article

A low dose of ionizing radiation increases luminal release of intestinal peptidases in ratsFITTKAU, Marina; GROTHEY, Axel; GERLACH, Reinhard et al.Journal of cancer research and clinical oncology. 2001, Vol 127, Num 2, pp 96-100, issn 0171-5216Article

Chemotherapy-induced peripheral neuropathy : Prevention and treatment strategiesWOLF, Sherry; BARTON, Debra; KOTTSCHADE, Lisa et al.European journal of cancer (1990). 2008, Vol 44, Num 11, pp 1507-1515, issn 0959-8049, 9 p.Article

Human hematopoietic growth factors : Old lessons and new perspectivesDEMPKE, Wolfram; VON POBLOZKI, Almut; GROTHEY, Axel et al.Anticancer research. 2000, Vol 20, Num 6D, pp 5155-5164, issn 0250-7005Article

Cyclooxygenase-2: a novel target for cancer chemotherapy?DEMPKE, Wolfram; RIE, Christoph; GROTHEY, Axel et al.Journal of cancer research and clinical oncology. 2001, Vol 127, Num 7, pp 411-417, issn 0171-5216Article

Evaluation of Alternate Categorical Tumor Metrics and Cut Points for Response Categorization Using the RECIST 1.1 Data WarehouseMANDREKAR, Sumithra J; AN, Ming-Wen; MEYERS, Jeffrey et al.Journal of clinical oncology. 2014, Vol 32, Num 8, pp 841-850, issn 0732-183X, 10 p.Article

Chemotherapy in advanced gastric cancer : A systematic review and Meta-analysis based on aggregate dataWAGNER, Anna D; GROTHE, Wilfried; HAERTING, Johannes et al.Journal of clinical oncology. 2006, Vol 24, Num 18, pp 2903-2909, issn 0732-183X, 7 p.Article

Bevacizumab exposure beyond first disease progression in patients with metastatic colorectal cancer: analyses of the ARIES observational cohort studyGROTHEY, Axel; FLICK, E. Dawn; COHN, Allen L et al.Pharmacoepidemiology and drug safety. 2014, Vol 23, Num 7, pp 726-734, issn 1053-8569, 9 p.Article

Pharmacogenetic Predictors of Adverse Events and Response to Chemotherapy in Metastatic Colorectal Cancer: Results From North American Gastrointestinal Intergroup Trial N9741MCLEOD, Howard L; SARGENT, Daniel J; GROTHEY, Axel et al.Journal of clinical oncology. 2010, Vol 28, Num 20, pp 3227-3233, issn 0732-183X, 7 p.Article

Evidence for Cure by Adjuvant Therapy in Colon Cancer : Observations Based on Individual Patient Data From 20,898 Patients on 18 Randomized TrialsSARGENT, Daniel; SOBRERO, Alberto; FRANCOIS SEITZ, Jean et al.Journal of clinical oncology. 2009, Vol 27, Num 6, pp 872-877, issn 0732-183X, 6 p.Article

Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies : Individual patient data from 20,898 patients on 18 randomized trialsSARGENT, Daniel J; WIEAND, Harry S; GROTHEY, Axel et al.Journal of clinical oncology. 2005, Vol 23, Num 34, pp 8664-8670, issn 0732-183X, 7 p.Article

C-erbB-2/HER-2 upregulates fascin, an actin-bundling protein associated with cell motility, in human breast cancer cell linesGROTHEY, Axel; HASHIZUME, Rintaro; HONG JI et al.Oncogene (Basingstoke). 2000, Vol 19, Num 42, pp 4864-4875, issn 0950-9232Article

Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium and Magnesium to Prevent Oxaliplatin-Induced Sensory Neurotoxicity (N08CB/Alliance)LOPRINZI, Charles L; RUI QIN; DAKHIL, Shaker R et al.Journal of clinical oncology. 2014, Vol 32, Num 10, pp 997-1005, issn 0732-183X, 9 p.Article

Comparison of Outcomes After Fluorouracil-Based Adjuvant Therapy for Stages II and III Colon Cancer Between 1978 to 1995 and 1996 to 2007: Evidence of Stage Migration From the ACCENT DatabaseQIAN SHI; ANDRE, Thierry; O'CONNELL, Michael J et al.Journal of clinical oncology. 2013, Vol 31, Num 29, pp 3656-3663, issn 0732-183X, 8 p.Article

Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trialGROTHEY, Axel; VAN CUTSEM, Eric; ADENIS, Antoine et al.Lancet (British edition). 2013, Vol 381, Num 9863, pp 303-312, issn 0140-6736, 10 p.Article

Intravenous Calcium and Magnesium for Oxaliplatin-Induced Sensory Neurotoxicity in Adjuvant Colon Cancer: NCCTG N04C7GROTHEY, Axel; NIKCEVICH, Daniel A; LOPRINZI, Charles L et al.Journal of clinical oncology. 2011, Vol 29, Num 4, pp 421-427, issn 0732-183X, 7 p.Article

Clinical Outcomes in Elderly Patients with Metastatic Colorectal Cancer Receiving Bevacizumab and Chemotherapy: Results from the BRiTE Observational Cohort StudyKOZLOFF, Mark F; BERLIN, Jordan; FLYNN, Patrick J et al.Oncology. 2010, Vol 78, Num 5-6, pp 329-339, issn 0030-2414, 11 p.Article

Association of HER2/ErbB2 Expression and Gene Amplification with Pathologic Features and Prognosis in Esophageal AdenocarcinomasYOON, Harry H; QIAN SHI; SINICROPE, Frank A et al.Clinical cancer research (Print). 2012, Vol 18, Num 2, pp 546-554, issn 1078-0432, 9 p.Article